Ledger.Open graph →
SEC Form D · filed March 8, 2016

Lung Therapeutics, Inc

Offering
$6.0M
Sold
$1.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
Austin, TX
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (14)

James B. Windsor · Austin, TXExec · DirectorAaron B. Fletcher · Carrollton, TXDirectorJoseph B. Woelkers · Tyler, TXDirectorSteven B. Idell · Tyler, TXDirectorRobert B. Mills · Naples, FLDirectorCatherine Bingham · London, United KingdomDirectorSusan L. Preston · Newcastle, WADirectorKathryn Stewart · LARKSPUR, CADirectorHamish Cameron · London, United KingdomDirectorMichael Ross · London, United KingdomExec · DirectorJeff Levine · Greenwood Village, CODirectorMark Schulman · Greenwood Village, CODirectorTimothy Chklovski · Los Angeles, CADirectorAlberto Siblesz · Miami, FLExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗